Results
|
1.
|
|
|
2.
|
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center. [electronic resource] by
- Wang, Yucai
- Tschautscher, Marcella A
- Rabe, Kari G
- Call, Timothy G
- Leis, Jose F
- Kenderian, Saad S
- Kay, Neil E
- Muchtar, Eli
- Van Dyke, Daniel L
- Koehler, Amber B
- Schwager, Susan M
- Slager, Susan L
- Parikh, Sameer A
- Ding, Wei
Producer: 20210423
In:
Haematologica vol. 105
Availability: No items available.
|
|
3.
|
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice. [electronic resource] by
- Hampel, Paul J
- Ding, Wei
- Call, Timothy G
- Rabe, Kari G
- Kenderian, Saad S
- Witzig, Thomas E
- Muchtar, Eli
- Leis, Jose F
- Chanan-Khan, Asher A
- Koehler, Amber B
- Fonder, Amie L
- Schwager, Susan M
- Slager, Susan L
- Shanafelt, Tait D
- Kay, Neil E
- Parikh, Sameer A
Producer: 20200828
In:
Leukemia & lymphoma vol. 60
Availability: No items available.
|
|
4.
|
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. [electronic resource] by
- Hampel, Paul J
- Call, Timothy G
- Ding, Wei
- Muchtar, Eli
- Kenderian, Saad S
- Wang, Yucai
- Leis, Jose F
- Witzig, Thomas E
- Koehler, Amber B
- Fonder, Amie L
- Schwager, Susan M
- Rabe, Kari G
- Van Dyke, Daniel L
- Braggio, Esteban
- Slager, Susan L
- Kay, Neil E
- Parikh, Sameer A
Producer: 20200512
In:
American journal of hematology vol. 95
Availability: No items available.
|
|
5.
|
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. [electronic resource] by
- Parikh, Sameer A
- Achenbach, Sara J
- Call, Timothy G
- Rabe, Kari G
- Ding, Wei
- Leis, Jose F
- Kenderian, Saad S
- Chanan-Khan, Asher A
- Koehler, Amber B
- Schwager, Susan M
- Muchtar, Eli
- Fonder, Amie L
- McCullough, Kristen B
- Nedved, Adrienne N
- Smith, Matthew D
- Slager, Susan L
- Kay, Neil E
- Finnes, Heidi D
- Shanafelt, Tait D
Producer: 20210903
In:
Cancer medicine vol. 9
Availability: No items available.
|
|
6.
|
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia. [electronic resource] by
- Paludo, Jonas
- Abeykoon, Jithma P
- Shreders, Amanda
- Ansell, Stephen M
- Kumar, Shaji
- Ailawadhi, Sikander
- King, Rebecca L
- Koehler, Amber B
- Reeder, Craig B
- Buadi, Francis K
- Dispenzieri, Angela
- Lacy, Martha Q
- Dingli, David
- Witzig, Thomas E
- Go, Ronald S
- Gonsalves, Wilson I
- Kourelis, Taxiarchis
- Warsame, Rahma
- Leung, Nelson
- Habermann, Thomas M
- Hayman, Suzanne
- Lin, Yi
- Kyle, Robert A
- Rajkumar, S Vincent
- Gertz, Morie A
- Kapoor, Prashant
Producer: 20180703
In:
Annals of hematology vol. 97
Availability: No items available.
|